Funding for this research was provided by:
National Human Genome Research Institute (ZIAHG200335)
National Institute of Diabetes and Digestive and Kidney Diseases (K18DK095473)
Received: 4 September 2018
Accepted: 28 February 2019
First Online: 12 March 2019
Ethics approval and consent to participate
: IRBs at the University of Cincinnati (2013–4924) and National Human Genome Research Institute (12-HG-N149) approved the study. Written and verbal consent were obtained before study participation.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.